文献速递慢性静脉疾病

症状性慢性髂股静脉梗阻患者支架尺寸选择技术:基于血管内超声测定的流入通道管腔面积选择支架的长期结局

Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-01-31

该研究纳入2015至2021年因生活质量受损的慢性髂股静脉梗阻且保守治疗失败而接受股髂腔静脉支架置入的300例患者(300条肢体),评估基于血管内超声(IVUS)测定的流入通道管腔面积选择支架尺寸的技术。支架置入后静脉临床严重程度评分(VCSS)、视觉模拟量表(VAS)疼痛评分、肿胀分级(GOS)和生活质量(CIVIQ-20)均显著改善,60个月一期、一期辅助和二期通畅率分别为84%、100%和100%,再干预率为10%。

要点

  • IVUS测定的流入通道管腔面积在>20 mm支架组为228 mm2,≤20 mm支架组为176 mm2(P < .0001)。
  • 支架置入后6周、3、6、12和24个月VCSS、VAS疼痛评分和GOS均显著改善(P < .0001),两组间无差异(P > .05)。
  • 整个队列CIVIQ-20评分从58改善至38(P < .0001),两组内亦均改善(P < .0001)。

核心结论

  • 基于IVUS测定的流入通道管腔面积选择支架尺寸,使生活质量受损的慢性髂股静脉梗阻患者支架置入后VCSS、VAS疼痛评分、GOS和生活质量(CIVIQ-20)显著改善。
  • 支架通畅率优良且再干预率低。
  • IVUS测定的流入通道管腔面积是一种客观的支架尺寸选择技术,优于现有主观技术。

研究设计与样本

  • 研究纳入2015至2021年因生活质量受损的慢性髂股静脉梗阻且保守治疗失败而接受股髂腔静脉支架置入的患者。
  • 共300例患者(300条肢体),中位年龄58岁,男性159/300,左侧176/300,血栓后综合征176/300,中位体重指数41。
  • >20 mm支架组120条肢体,≤20 mm支架组180条肢体,中位随访23个月。
  • 比较两组临床结局、生活质量和支架结局,采用t检验和方差分析比较结局,Kaplan-Meier分析评估通畅率并用log rank比较曲线。

主要发现

  • 两组基线VCSS、VAS疼痛评分和GOS无显著差异。
  • IVUS测定的流入通道管腔面积>20 mm支架组为228 mm2,≤20 mm支架组为176 mm2(P < .0001)。
  • 支架置入后6周、3、6、12和24个月VCSS、VAS疼痛评分和GOS均显著改善(P < .0001),两组间无差异(P > .05)。
  • 整个队列CIVIQ-20评分从58改善至38(P < .0001),两组内亦均改善(P < .0001)。
  • 60个月总体一期、一期辅助和二期通畅率分别为84%、100%和100%,再干预率为10%,两组间无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Femoroiliocaval stenting has become the standard of care for patients with quality-of-life impairing chronic iliofemoral venous obstruction not responding to conservative measures. Although improvement after stenting has been noted in multiple large studies, sizing of stents has been subjective in nature with a general tendency to use smaller stents that would be required to relieve venous hypertension. This study evaluates the authors' technique of using the intravascular ultrasound (IVUS) inflow channel luminal area to guide stent sizing. METHODS: Patients who underwent femoroiliocaval stenting for quality-of-life impairing chronic iliofemoral venous obstruction and had failed conservative therapy from 2015 to 2021 were included in the study. Clinical outcomes including venous clinical severity score (VCSS), visual analog scale (VAS) pain score, and grade of swelling (GOS) were appraised before and after stenting. Also evaluated were quality of life (Chronic Venous Insufficiency Questionnaire-20 [CIVIQ-20] instrument) and stent outcomes including patencies and reinterventions. Comparisons were made between limbs that underwent placement of larger caliber stents (largest stent diameter >20 mm: >20 mm stent group) vs smaller caliber stents (largest stent diameter ≤20 mm: ≤20 mm stent group). t tests and analysis of variance were used to compare outcomes, whereas the Kaplan-Meier analysis was used to evaluate patencies with log rank used to compare the curves. RESULTS: A total of 300 patients (300 limbs) underwent stenting with a median age of 58 years. There was a preponderance of men (159 of 300), left laterality (176 of 300), and post-thrombotic syndrome (176 of 300). The median body mass index was 41. There were 120 limbs in the >20 mm stent group and 180 limbs in the ≤20 mm stent group. The median follow-up was 23 months. There was no significant difference in baseline VCSS, VAS pain score, or GOS between the two groups. However, there was a significant difference in IVUS-determined inflow channel luminal area between the two groups (228 mm2 >20 mm stent group vs 176 mm2 for ≤20 mm stent group [P < .0001]). After stenting there was a significant improvement in the VCSS, VAS pain score, and GOS at 6 weeks, 3, 6, 12, and 24 months (P < .0001) without any difference between the groups (P > .05). The CIVIQ-20 score also improved from 58 to 38 (P < .0001) for the entire cohort and for the two groups (P < .0001). Overall primary, primary-assisted, and secondary patencies at 60 months were 84%, 100%, and 100%, respectively. Reintervention rate was 10% without any difference between the groups. CONCLUSIONS: Stent sizing using IVUS-determined inflow channel luminal area in patients undergoing stenting for quality-of-life impairing chronic iliofemoral venous obstruction resulted in a significant improvement in the VCSS, VAS pain score, GOS, and quality of life (CIVIQ-20) after stenting. Excellent stent patencies and low reintervention rates were also noted. IVUS-determined inflow channel luminal area represents an objective technique of stent sizing in comparison to the subjective techniques that currently exist.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Jayaraj A, Thaggard D, Lucas M, et al. Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36731654. doi:10.1016/j.jvsv.2022.12.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。